Related Experiment Videos
Nucleolar organizer regions argyrophilic associated proteins in cutaneous melanocytic lesions
J P Reis1, O Tellechea, A P Baptista
1Department of Dermatology, University Hospital, Coimbra, Portugal.
Abstract:
We applied a simple silver staining technique to visualize nucleolar organizer regions associated proteins (AgNORs) for the study of 47 melanocytic lesions (20 malignant melanomas, 5 dysplastic nevi, 4 Spitz nevi, 2 Reed and Gartman's fusiform nevi and 16 melanocytic nevi). A statistically significant difference existed between the numbers of AgNORs per cell in benign and malignant lesions as a group. However, some overlapping counts were found, limiting the usefulness of the technique in differentiating benign from malignant lesions in individual cases.
Insights
Silver staining of AgNORs (nucleolar organizer regions associated proteins) showed significant differences between benign and malignant melanocytic lesions. However, overlapping counts limit its use for individual case diagnosis.
Area of Science:
- Dermatopathology
- Cell Biology
- Histology
Background:
- Melanocytic lesions require accurate diagnosis to distinguish benign from malignant types.
- Nucleolar organizer regions associated proteins (AgNORs) are involved in cell proliferation and have been investigated as diagnostic markers.
Purpose of the Study:
- To evaluate the utility of silver staining for visualizing AgNORs in melanocytic lesions.
- To determine if AgNOR counts can differentiate between benign and malignant melanocytic lesions.
Main Methods:
- A simple silver staining technique was used to visualize AgNORs.
- AgNOR counts per cell were analyzed in 47 melanocytic lesions, including malignant melanomas, dysplastic nevi, and various benign nevi.
Main Results:
- A statistically significant difference in the mean number of AgNORs per cell was observed between benign and malignant lesions as a group.
- Overlapping AgNOR counts were found between benign and malignant lesions, indicating potential diagnostic ambiguity in individual cases.
Conclusions:
- Silver staining for AgNORs can reveal differences in proliferation markers between benign and malignant melanocytic lesions.
- While group differences are significant, the overlap in AgNOR counts limits the technique's reliability for definitive diagnosis of individual melanocytic lesions.